OP Asset Management’s ADMA Biologics ADMA Stock Holding History

OP Asset Management’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$323K	Buy	+38,648	New	+$352K	﹤0.01%	696
2026 Q1	–	Sell	-271,192	Closed	-$4.95M	–	786
2025 Q4	$4.95M	Buy	271,192 +157,602	+139%	+$2.66M	0.06%	235
2025 Q3	$1.67M	Buy	113,590 +33,848	+42%	+$580K	0.02%	482
2025 Q2	$1.45M	Buy	79,742 +58,279	+272%	+$1.19M	0.02%	518
2025 Q1	$426K	Buy	+21,463	New	+$371K	0.01%	686

Other funds holding ADMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

OP Asset Management's ADMA Position: Q2 2026 in Review

OP Asset Management opened a new position in ADMA Biologics (ADMA) in Q2 2026: 38,648 shares worth $323K. The stake represents ﹤0.01% of the portfolio and ranks #696 among its holdings. This is a return to the name: OP Asset Management previously reported a position in ADMA as recently as Q4 2025.

OP Asset Management first reported a position in ADMA in Q1 2025 and has held it in 5 quarters since. The position peaked at $4.95M in Q4 2025. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

OP Asset Management held 38,648 shares of ADMA Biologics worth $323K as of Q2 2026.
ADMA Biologics was a new OP Asset Management position in Q2 2026.
ADMA Biologics made up ﹤0.01% of OP Asset Management's portfolio in Q2 2026, its #696 holding.
OP Asset Management first reported a position in ADMA Biologics in Q1 2025 and has held it in 5 quarters since.
OP Asset Management's ADMA Biologics position peaked at $4.95M in Q4 2025.
322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.